Amdocs [DOX] vs Oracle [ORCL] Detailed Stock Comparison
Amdocs
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Amdocs wins in 11 metrics, Oracle wins in 7 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amdocs | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.68 | 58.19 | Amdocs |
| Price-to-Book Ratio | 2.81 | 34.66 | Amdocs |
| Debt-to-Equity Ratio | 23.65 | 519.59 | Amdocs |
| PEG Ratio | 12.65 | 35.27 | Amdocs |
| EV/EBITDA | 9.96 | 34.39 | Amdocs |
| Profit Margin (TTM) | 11.94% | 21.68% | Oracle |
| Operating Margin (TTM) | 17.69% | 32.48% | Oracle |
| EBITDA Margin (TTM) | 17.69% | 32.48% | Oracle |
| Return on Equity | 15.73% | 82.38% | Oracle |
| Return on Assets (TTM) | 7.87% | 7.26% | Amdocs |
| Free Cash Flow (TTM) | $618.93M | $-394.00M | Amdocs |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 7.71% | 89.35% | Oracle |
| Price-to-Sales Ratio (TTM) | 2.13 | 12.36 | Amdocs |
| Enterprise Value | $9.89B | $807.58B | Oracle |
| EV/Revenue Ratio | 2.13 | 14.07 | Amdocs |
| Gross Profit Margin (TTM) | 38.13% | 70.19% | Oracle |
| Revenue per Share (TTM) | $41 | $21 | Amdocs |
| Earnings per Share (Diluted) | $4.76 | $4.34 | Amdocs |
| Beta (Stock Volatility) | N/A | 1.43 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amdocs vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amdocs | 0.61% | 5.82% | -3.47% | -3.39% | 4.21% | 6.24% |
| Oracle | 0.26% | 2.30% | 6.63% | 66.37% | 39.76% | 50.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amdocs | 7.71% | 0.53% | 44.69% | 48.02% | 241.04% | 197.77% |
| Oracle | 89.35% | 215.92% | 361.35% | 534.48% | 1,003.49% | 1,780.08% |
Performance & Financial Health Analysis: Amdocs vs Oracle
| Metric | DOX | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $9.89B | $709.31B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 697,190 | 9,447,430 |
| 90 Day Avg. Volume | 727,940 | 13,061,150 |
| Last Close | $89.41 | $250.05 |
| 52 Week Range | $78.61 - $95.41 | $118.86 - $260.87 |
| % from 52W High | -6.29% | -4.15% |
| All-Time High | $99.75 (Jun 26, 2023) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -10.37% | -4.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.08% | 0.11% |
| Quarterly Earnings Growth | 0.10% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.22% |
| Operating Margin (TTM) | 0.18% | 0.32% |
| Return on Equity (TTM) | 0.16% | 0.82% |
| Debt to Equity (MRQ) | 23.65 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $31.67 | $7.29 |
| Cash per Share (MRQ) | $3.10 | $3.99 |
| Operating Cash Flow (TTM) | $737.18M | $20.82B |
| Levered Free Cash Flow (TTM) | $560.12M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Amdocs vs Oracle
| Metric | DOX | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.68 | 58.19 |
| Forward P/E | 12.65 | 35.27 |
| PEG Ratio | 12.65 | 35.27 |
| Price to Sales (TTM) | 2.13 | 12.36 |
| Price to Book (MRQ) | 2.81 | 34.66 |
| Market Capitalization | ||
| Market Capitalization | $9.89B | $709.31B |
| Enterprise Value | $9.89B | $807.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.13 | 14.07 |
| Enterprise to EBITDA | 9.96 | 34.39 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.43 |
| Book Value per Share (MRQ) | $31.67 | $7.29 |
Financial Statements Comparison: Amdocs vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOX | ORCL |
|---|---|---|
| Revenue/Sales | $1.13B | $15.90B |
| Cost of Goods Sold | $698.05M | $4.74B |
| Gross Profit | $430.15M | $11.16B |
| Research & Development | $81.80M | $2.65B |
| Operating Income (EBIT) | $197.74M | $5.19B |
| EBITDA | $244.14M | $7.00B |
| Pre-Tax Income | $189.27M | $4.15B |
| Income Tax | $25.27M | $725.00M |
| Net Income (Profit) | $164.00M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOX | ORCL |
|---|---|---|
| Cash & Equivalents | $247.39M | $10.79B |
| Total Current Assets | $1.56B | $24.58B |
| Total Current Liabilities | $1.34B | $32.64B |
| Long-Term Debt | $748.93M | $96.83B |
| Total Shareholders Equity | $3.50B | $20.97B |
| Retained Earnings | N/A | $-15.48B |
| Property, Plant & Equipment | $874.85M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOX | ORCL |
|---|---|---|
| Operating Cash Flow | $195.07M | $5.93B |
| Capital Expenditures | $-15.96M | N/A |
| Free Cash Flow | $156.49M | $-2.92B |
| Debt Repayment | N/A | $-6.07B |
| Common Stock Repurchase | $-135.24M | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | DOX | ORCL |
|---|---|---|
| Shares Short | 3.93M | 20.68M |
| Short Ratio | 5.04 | 1.27 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 697,190 | 9,447,430 |
| Average Daily Volume (90 Day) | 727,940 | 13,061,150 |
| Shares Outstanding | 112.89M | 2.81B |
| Float Shares | 108.54M | 1.64B |
| % Held by Insiders | 0.00% | 0.42% |
| % Held by Institutions | 1.00% | 0.45% |
Dividend Analysis & Yield Comparison: Amdocs vs Oracle
| Metric | DOX | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |